Products - Cyprus Market

Disclaimer: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.

Download PDF
Product Name Strength and Dosage form Brand/Innovator Indication Dossier Availability
ABEMACICLIB 50mg, 100mg, 150mg Film-coated tablets Verzenios® (Eli Lilly) Breast cancer Q4-2026
ANASTROZOLE 1mg Film-coated tablets Arimidex® (AstraZeneca) Breast cancer YES
EXEMESTANE 25mg Film-coated tablets Aromasin® (Pfizer) Breast cancer YES
LAPATINIB 250mg Film-coated tablets Tyverb® (Novartis) Breast cancer YES
LETROZOLE 2.5mg Film-coated tablets Femara® (Novartis) Breast cancer YES
RIBOCICLIB 200mg Film-coated tablets Kisqali® (Novartis) Breast cancer Q4-2026
TAMOXIFEN 10mg, 20mg Tablets Nolvadex® (AstraZeneca) Breast cancer Q3-2025
CAPECITABINE 150mg, 500mg Film-coated tablets Xeloda® (Roche) Colon cancer, gastric cancer, breast cancer YES
SUNITINIB 12.5mg, 25mg, 37.5mg, 50mg Capsules, hard Sutent® (Pfizer) Gastric cancer, Renal cell cancer, Pancreatic cancer YES
SORAFENIB 200mg Film-coated tablets Nexavar® (Bayer) Hepatocellular carcinoma YES

* Available for distribution only.